Skip to main content
Clinical Trials/ACTRN12615000910505
ACTRN12615000910505
Recruiting
Phase 4

In patients presenting to the Emergency Department with acute migraine, is propofol more effective than placebo for headache resolution by one hour.

Dandenong Hospital0 sites60 target enrollmentSeptember 1, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Neurological - Other neurological disorders
Sponsor
Dandenong Hospital
Enrollment
60
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dandenong Hospital

Eligibility Criteria

Inclusion Criteria

  • Acute migraine, 18 to 65 years of age, patient reported pain on arrival of severity of 4 or more on the 1 to 10 numerical rating scale.

Exclusion Criteria

  • Any doubt about diagnosis of migraine for any reason, any associated head injury, any known intracranial pathology, systolic blood pressure less than100 mmHg, use of defined drugs in previous 4 hours (opioids, ergotamine, triptans, neuroleptics or antemetics other than ondansetron), known allergy to propofol, intralipid, egg or soy products. Migraine WITH aura comprising of neurological symptoms, aura being defined as: at least 2 of these, fully reversible aura symptoms: visual symptoms (flickering lights/spots/lines/visual loss) or Sensory symptoms (pins/needles/numbness), or Dysphasic speech disturbance; And at least 2 of these: Homonymous visual and/or unilateral sensory symptoms or at least one aura symptom developing over \> 5 min, or Aura symptom(s) lasting between 5 and 60 minutes

Outcomes

Primary Outcomes

Not specified

Similar Trials